Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: Meta-analysis of randomised controlled trials using individual patient data

BMJ

Volumn 343, Issue 7815, 2011, Pages

  Pickup, John C ^a   Freeman, Suzanne C ^b,c   Sutton, Alex J ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD GLUCOSE SELF MONITORING; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTERMETHOD COMPARISON; META ANALYSIS; MONITOR; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME CONTINUOUS GLUCOSE MONITORING; SELF MONITORING;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960319709     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d3805     Document Type: Article

References (24)

1. Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes Technol Therapeut 2000;2:13-8.
2. st century diabetes therapy. Diabetes Care 2005;28:1231-9.
3. Deiss D, Bollinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730-2. (Pubitemid 44912209)
4. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Therapeut 2008;10:377-83.
5. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-76.
6. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-83.
7. O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trials. Diabetologia 2009;52:1250-70.
8. Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hamaire H, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes. Diabetes Care 2009;32:2245-50.
9. Juvenile Diabetes Foundation Continuous Glucose Monitoring Study Group. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009;32:1947-53.
10. Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient level covariates in meta-regression with individual patient data meta-analyses. J Clin Epidemiol 2002;55:86-94. (Pubitemid 34037039)
11. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010;340:c221.
12. Hermanides J, Nøgaard K, Brutomesso D, Mathieu C, Frid A, Dyan CM, et al. Sensor augmented pump therapy substantially lowers HbA1c: a randomized controlled trial. Diabetologia 2009;52:S43 (Abstract).
13. Bergenstall RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Effectiveness of sensor-augmented insulin pump therapy in type 1 diabetes. N Engl J Med 2010;311-20.
14. Jadad AR, Moore RA, Carroll D, Jenkinson CJ, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
15. American Diabetes Association Working Group on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005;28:1245-9.
16. Spiegelhalter DJ, Best NG, Carline BP, Van der Linde A. Bayesian measures of model complexity and fit. J Roy Stat Soc Series B 2002;64:583-640.
17. Riley RD, Steyerberg EW. Meta-analysis of a binary outcome using individual participant data and aggregate data. Res Synth Meth 2010;1:2-19.
18. Bagos PG, Nikolopoulos GK. Mixed-effects Poisson regression models for meta-analysis of follow up studies with constant or varying durations. Int J Biostat 2009;5:21:article 21.
19. Egger M, Davey Smith G, Altman DG. Systematic reviews in health care: meta-analysis in context. BMJ Publishing Group, 2001.
20. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-60.
21. Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-98.
22. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomised controlled trials: current issues and future directions. Int J Technol Assess Healthcare 1996;12:195-208. (Pubitemid 26195520)
23. Higgins JPT, Green S,eds. Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cohrane-handbook.org.
24. Hammond PJ, Amiel SA, Dayan CM, Kerr D, Pickup JC, Shaw JAM, et al. ABCD position statement on continuous glucose monitoring: use of glucose sensing in outpatient clinical diabetes care. Pract Diab Int 2010;27:1-3.